Research Projects & Grants

For Profit Organization

  • A randomized, double-blind, placebo-controlled, phase 3 study to evaluate the efficacy, safety, and tolerability of JNJ-27018966 in the treatment of patients with diarrhea-predominant irritable bowel syndrome, Role: Investigator, Furiex Pharmaceuticals, (07/2012 - 07/2013) Status: Completed
  • Prospective observational study on predictors of early on-treatment response and sustained virological response in a cohort of treatment naive HCV-infected patients treated with pegylated interferons, Role: Investigator, Hoffmann-La Roche Inc., (11/2010 - 11/2011) Status: Completed
  • Multicenter, randomized, open-labeled, controlled study of the effect of treatment with once weekly Pegasys® plus daily Copegus® with or without concomitant pioglitazone (Actos®) on early viral kinetics in treatment-naive patients with chronic hepatitis C (genotype-1 HCV infection) and insulin resistance, Role: Investigator, Hoffmann-La Roche Inc., (08/2010 - 08/2011) Status: Completed
  • A multicenter, open-labeled study of the long-term safety and efficacy of lubiprostone in patients with opioid-induced bowel dysfunction, Role: PI, Sucampo Pharmaceuticals, Inc., (09/2009 - 09/2010) Status: Completed
  • A randomized double-blind parallel study of rabeprazole extended-release 50 mg versus esomeprazole 40 mg for healing and symptomatic relief of moderate to severe erosive gastroesophageal reflux disease (GERD), Role: PI, Eisai Medical Research, Inc., (02/2009 - 02/2010) Status: Completed
  • A multicenter, randomized, placebo-controlled, doubleblinded study of the efficacy and safety of lubiprostone in patients with opioid-induced bowel dysfuction, Role: PI, Sucampo Pharmaceuticals, Inc., (01/2009 - 01/2010) Status: Completed

Internal

  • Percutaneous jejunostomy feeding tubes: A case series in pregnant patients, Role: PI, LLU Dept. of Gastroenterology, (03/2009 - 03/2010) Status: Completed
  • Expected rate of decline of liver enzymes after a successful ERCP for obstructive jaundice, Role: PI, LLU Dept. of Medicine, (01/2008 - 01/2009) Status: Completed
  • Chlorhexidine versus povidone-iodine as cutaneous antisepsis for prevention of PEG site infection - a pilot study, Role: PI, LLU Dept. of Medicine, (08/2007 - 08/2008) Status: Completed